La vitamine marketing: quelques réponses aux mutations actuelles de l'industrie pharmaceutiqueTEMPE, B; DUNAIGRE, T; ROUQUETTE, H et al.1992, 95 p.Book

Le financement optimal des investissements en ressources humaines: le cas des médicaments dans les pays de l'Afrique subsaharienneKLIMEK, C; ORIVEL, F.sd, 583 p.Thesis

Innovation ouverte: optimiser les partenariats entre sociétés de biotech, industrie pharmaceutique et acteurs académiques = Open innovation: optimize partnerships between biotechs, pharmas and academiaBERTRAND, K.STP pharma pratiques. 2011, Vol 21, Num 5, pp 349-352, issn 1157-1497, 4 p.Conference Paper

Médecins et médicaments : Un regard sociologiqueVEGA, Anne.Médecine (Montrouge). 2009, Vol 5, Num 3, pp 133-136, issn 1777-2044, 4 p.Article

Le docteur Knock habite à Wall Street : Les nouvelles cibles de l'industrie pharmaceutique = Doctor Knock lives at Wall Street: The new targets of pharmaceutical industryCATHEBRAS, P.La Revue de médecine interne (Paris). 2003, Vol 24, Num 8, pp 538-541, issn 0248-8663, 4 p.Article

Process analytical technologies in the pharmaceutical industry : the FDA's PAT initiative : Process analytical chemistryHINZ, Dirk C.Analytical and bioanalytical chemistry. 2006, Vol 384, Num 5, pp 1036-1042, 7 p.Article

A PROPOS DE POSTES DE SECURITE DANS L'INDUSTRIE PHARMACEUTIQUEHERVOUET JP.1976; ARCH. MAL. PROF.; FR.; DA. 1976; VOL. 37; NO 3; PP. 256-262; (13EMES. JOURN. NATL. MED. TRAV. II; TOURS; 1974)Conference Paper

The American Society for Clinical Pharmacology and Therapeutics and the pharmaceutical industryABRAMS, W. B.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 2, pp 282-286, issn 0009-9236Article

Fortschritte auf dem Gebiet der Arzneimittelentwicklung. XIX = Progrès dans la recherche pharmaceutique. XIX = Progress in the field of drug development XIXDELENK-HEYDENREICH, K; HENKLER, G; KELLER, U et al.Pharmazie. 1986, Vol 41, Num 9, pp 617-626, issn 0031-7144Article

Médicaliser/démédicaliser : développer l'expertise des patients : Le marché de la souffrance psychique = MEDICALISING/DEMEDICALISING : DEVELOPING THE EXPERTISE OF THE PATIENTS THEMSELVESPIGNARRE, Philippe.Cliniques méditerranéennes. 2008, Num 77, pp 125-136, issn 0762-7491, 12 p.Article

Industrie pharmaceutique: logistique de distributionGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2007, Vol AGL1, Num AG5435, issn 1282-9072, AG5435.1-AG5435.18Article

Results from a bench marking survey on cassette dosing practices in the pharmaceutical industryACKERMANN, Bradley L.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 9, pp 1374-1377, issn 1044-0305, 4 p.Article

Logistik und Verfahrenstechnik in der Fabrik 2000 = Logistics and process technology in the factory of the year 2000FINK, M; SIMON, R. W.Pharmazeutische Industrie. 1995, Vol 57, Num 6, pp 507-509, issn 0031-711X, 3 p.Article

Industry and academia in collaboration: the Pfizer experiencePRICE, F. D.Circulation (New York, N.Y.). 1985, Vol 72, Num 2, pp 13-17, issn 0009-7322Article

Strategies for improving drug development in the early phaseGRIGOLEIT, H.-G.Pharmazeutische Industrie. 1984, Vol 46, Num 5, pp 521-525, issn 0031-711XArticle

Information requirements for chemists in the pharmaceutical industryBROWN, H. D.Journal of chemical information and computer sciences. 1984, Vol 24, Num 3, pp 155-158, issn 0095-2338Article

NEW DRUG DEVELOPMENT BY UNITED STATES PHARMACEUTICAL FIRMS WITH ANALYSES OF TRENDS IN THE ACQUISITION AND ORIGIN OF DRUG CANDIDATES, 1963-1979WARDELL WM; MAY MS; TRIMBLE AG et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 38; NO 4; PP. 407-417; BIBL. 10 REF.Article

Les ambitions d'Ingérop dans l'ingénierie pharmaceutique : Pharmacie = Ingerop's ambitions in pharmaceutical engineeringSAVOSTIANOFF, Dmitri.Info chimie magazine. 2000, Num 423, pp 102-103, issn 1286-0921Article

ADRENOCORTICAL SUPPRESSION IN WORKERS EMPLOYED IN MANUFACTURING SYNTHETIC GLUCOCORTICOSTEROIDS. SOLUTIONS TO A PROBLEMNEWTON RW; BROWNING MCK; NICHOLSON PC et al.1982; BR. J. IND. MED.; ISSN 0007-1072; GBR; DA. 1982; VOL. 39; NO 2; PP. 179-182; BIBL. 2 REF.Article

NEW POWER PLANT FOR GLAXO LABORATORIES = NOUVELLE CENTRALE THERMIQUE POUR LES LABORATOIRES GLAXOVALENTINE AC.1974; HEATG AIR CONDITIONG J.; G.B.; DA. 1974; VOL. 44; NO 516; PP. 30-40Article

Having the last laugh at big pharmaCOOMBES, Rebecca.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7590, pp 396-397, issn 0959-8146, 2 p.Article

Upping the ante on antibodies : Antibody engineering and manufactureBAKER, Monya.Nature biotechnology. 2005, Vol 23, Num 9, pp 1065-1072, issn 1087-0156, 8 p.Article

Biotechnology and rules governing pharmaceuticals in the european communitySAUER, F.Therapeutic agents produced by genetic engineering: Quo Vadis? Symposium. 1986, pp 197-207Conference Paper

Stratégies de diversification dans le secteur biopharmaceutiqueLE, Philippe; HARA, Liuichi; GANESAN, Balaji et al.Biofutur (Puteaux). 2011, Num 326, pp 60-62, issn 0294-3506, 3 p.Article

Ghosts in the Machine: Comment on SismondoMCHENRY, Leemon.Social studies of science. 2009, Vol 39, Num 6, pp 943-947, issn 0306-3127, 5 p.Article